Flegamax contains carbocisteine as an active substance , which affects the composition of bronchial secretions. Carbocisteine causes the secretion to be less viscous and more fluid , which makes it easier to remove from the respiratory tract during coughing (so-called mucolytic effect).
Indications
Active substance: Carbocysteine
Composition
| 1 ml of solution contains: | 50 mg of active substance carbocisteine |
| other ingredients are: sodium saccharin, methyl parahydroxybenzoate, raspberry flavour (ingredients: maltodextrin (from maize), modified starch (E 1450), flavours identical to nature, flavour preparation), cochineal red (E 124), sodium hydroxide, carboxymethylcellulose, purified water, sodium hydroxide, 1N aqueous solution (to adjust pH). |
Dosage
Always use this medicine exactly as described in the package leaflet or as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
Oral administration. 15 ml of the drug contains 750 mg of carbocisteine. A measuring cup is included in the package, which allows you to measure the appropriate volume of the drug. Recommended dose Adults and adolescents over 12 years of age: Initially, a dose of 15 ml of the drug should be used 3 times a day, and then, after the occurrence of a mucolytic effect (thinning secretions), the dose should be reduced to 10 ml of the drug 3 times a day.
Use of the drug in children and adolescents
Flegamax is not intended for use in children under 6 years of age.
Children aged 6 to 12 years: 5 ml of the drug 3 times a day. In children and adolescents, the daily dose of carbocisteine cannot exceed 30 mg/kg b.w. It is recommended that the child wash down the dose of the drug with water.
Do not use the medicine for more than 4 to 5 days without a doctor’s recommendation. During treatment, you should drink more fluids. Do not use the medicine before going to bed. The last dose should be taken no later than 4 hours before going to bed.
Contraindications
Do not use Flegamax:
- if you are allergic to carbocisteine or any of the other ingredients of this medicine
- in an asthmatic state,
- if you have an active stomach or duodenal ulcer,
- in children under 6 years of age.
Notes on use
Flegamax contains cochineal red (E 124), methyl parahydroxybenzoate, sodium
The drug may cause allergic reactions (possibly delayed).
The medicine contains 7.6 to 8.1 mg of sodium (the main component of table salt) in each ml. This corresponds to 0.38 to 0.41% of the maximum recommended daily intake of sodium in the diet for adults.
Contents:
Flegamax is a red, transparent solution. PET bottle closed with an aluminum cap, with an attached PP measuring cup with a capacity of 15 ml, in a cardboard box. The package contains 120 ml of oral solution.
Storage method: below 25°C
Manufacturer address:
Polpharma S.A.
ul. Pelplińska 19
83-200 Starogard Gdański
Poland
Reviews
Clear filtersThere are no reviews yet.